Clinical Trials Logo

Clinical Trial Summary

This study compares contact lens comfortable wear duration, and signs and symptoms of contact lens discomfort, test versus control.


Clinical Trial Description

The clinical hypothesis is that CLM2 topical gel applied dermally on the forehead twice daily will be more effective than placebo (a) in reducing or eliminating ocular discomfort associated with contact lens wear, (b) prolong hours of comfortable wear, (c) prolong total hours of contact lens wear, (d) improve ease of insertion and removal of contact lens, and ( c) reduces friction between cornea/lens and lens/eyelid, without use of artificial eye drops or gels. One mechanism supporting this hypothesis is preliminary evidence of increased meibum secretion following CLM2 topical gel application. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03994406
Study type Interventional
Source Glia, LLC
Contact
Status Completed
Phase Phase 2
Start date June 27, 2019
Completion date October 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT03682809 - Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort Phase 4
Completed NCT05416528 - Chinese Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8)
Completed NCT05548491 - Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD) Phase 2
Completed NCT03311204 - The Effect of Eyelid Margin Debridement on Contact Lens Discomfort N/A
Active, not recruiting NCT03652337 - Meibomian Gland Dysfunction Management N/A
Not yet recruiting NCT05801991 - Neurolens and Contact Lens Discomfort N/A
Completed NCT02848222 - Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers N/A
Completed NCT03686878 - Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness Phase 4